ResearcherNational Institutes of HealthActive in the last 2 years

Leela Rani Avula

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9920-9506; OpenAlex author ID A5032389760. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

Excess shed mesothelin disrupts pancreatic cancer cell clustering to impair peritoneal colonization. Co-author DOI 10.1096/fj.202400446r ↗
Molecular mediators of peritoneal metastasis in pancreatic cancer. Co-author DOI 10.1007/s10555-020-09924-4 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Christine Alewine · 2 shared papers, 2020–2024 · strength 0.41
- Paper Excess shed mesothelin disrupts pancreatic cancer cell clustering to impair peritoneal colonization. DOI 10.1096/fj.202400446r ↗
- Paper Molecular mediators of peritoneal metastasis in pancreatic cancer. DOI 10.1007/s10555-020-09924-4 ↗
Theressa Ewa · 1 shared paper, 2024 · strength 0.22
- Paper Excess shed mesothelin disrupts pancreatic cancer cell clustering to impair peritoneal colonization. DOI 10.1096/fj.202400446r ↗
Brendan L. Hagerty · 1 shared paper, 2020 · strength 0.19
- Paper Molecular mediators of peritoneal metastasis in pancreatic cancer. DOI 10.1007/s10555-020-09924-4 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.